Research

Investigatory Medications

Kindolor is a non-opiate, non-addicting molecule that was developed specifically to attenuate the aberrant over-activity of the peripheral nociceptive sensory pathway underlying the development and propagation of chronic pain.
Nezavist is a unique, non-addicting medication that reduces the increased alcohol consumption accompanying withdrawal in alcohol-dependent individuals as well as the hyperexcitability, anxiety, depression, and craving to return to drinking that accompanies abstinence.

Lohocla Research Development Pipeline

Preclinical
Discovery
Lead
Lead Optimization
Efficacy
in vitro
in vivo
Pharmacokinetics
in vitro
in vivo
Safety
in vitro
in vivo
IND
Phase I
Phase II
Nezavist
Kindolor
LOH100